Iván Mascanfroni

6.2k total citations
29 papers, 2.7k citations indexed

About

Iván Mascanfroni is a scholar working on Immunology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Iván Mascanfroni has authored 29 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Genetics. Recurrent topics in Iván Mascanfroni's work include Immune Response and Inflammation (8 papers), Immunotherapy and Immune Responses (6 papers) and Thyroid Disorders and Treatments (6 papers). Iván Mascanfroni is often cited by papers focused on Immune Response and Inflammation (8 papers), Immunotherapy and Immune Responses (6 papers) and Thyroid Disorders and Treatments (6 papers). Iván Mascanfroni collaborates with scholars based in Argentina, United States and Canada. Iván Mascanfroni's co-authors include Francisco J. Quintana, Ada Yeste, Bonny Patel, Gabriel A. Rabinovich, Juan P. Cerliani, Meghan Nadeau, Diego O. Croci, Lior Mayo, Santiago P. Méndez‐Huergo and Simon C. Robson and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Iván Mascanfroni

26 papers receiving 2.7k citations

Peers

Countries citing papers authored by Iván Mascanfroni

Since Specialization

Citations

This map shows the geographic impact of Iván Mascanfroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Mascanfroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Mascanfroni more than expected).

Fields of papers citing papers by Iván Mascanfroni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Mascanfroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Mascanfroni. The network helps show where Iván Mascanfroni may publish in the future.

Co-authorship network of co-authors of Iván Mascanfroni

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Mascanfroni. A scholar is included among the top collaborators of Iván Mascanfroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Mascanfroni. Iván Mascanfroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic IgG- and IgM-specific proteases disarm the acetylcholine receptor autoantibodies that drive myasthenia gravis pathology 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Alex Pellerin, (unknown), Agustín Plasencia, Jordan M. Anderson, (unknown), Valentina Damato, Luca Massacesi, Minh Pham, (unknown), (unknown), (unknown), Kevin L. Otipoby, Xing Yi, Iván Mascanfroni, Kevin C. O’Connor	0
2	Preclinical Polypharmacology of S-1117, a Novel Engineered Fc-Fused IgG Degrading Enzyme, for Chronic Treatment of Autoantibody-Mediated Diseases 2024 ·Blood ·Julia Manasson, Liliana M. Sanmarco, Alex Pellerin, Jordan M. Anderson, Nathan Rollins, (unknown), Agustín Plasencia, Andita Newton, Ryan Peckner, Xing Yi, (unknown), (unknown), John S. Sundy, Kevin L. Otipoby, Iván Mascanfroni	3
3	Multi-Omics Characterization of Colon Mucosa and Submucosa/Wall from Crohn’s Disease Patients 2024 ·International Journal of Molecular Sciences ·Liang Jin, Michael Macoritto, (unknown), Yingtao Bi, Fei Wang, Abel Suárez‐Fueyo, Jesus Paez‐Cortez, Chenqi Hu, Heather Knight, Iván Mascanfroni, Matthew Staron, (unknown), (unknown), Susan V. Westmoreland, (unknown)	0
4	In vivo PK/PD assessment of invisibilized IgG cleaving protease for chronic treatment of autoimmune diseases 2023 ·The Journal of Immunology ·Liliana M. Sanmarco, Alex Pellerin, (unknown), Andita Newton, (unknown), (unknown), Shanell Mojta, (unknown), (unknown), Kevin L. Otipoby, Iván Mascanfroni	0
5	Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α 2015 ·Nature Medicine ·Iván Mascanfroni, Maisa C. Takenaka, Ada Yeste, Bonny Patel, Yan Wu, Jessica E. Kenison, Shafiuddin Siddiqui, Alexandre S. Basso, Leo E. Otterbein, Drew M. Pardoll, Fan Pan, Avner Priel, Clary B. Clish, Simon C. Robson, Francisco J. Quintana	342
6	Differential Response of Myeloid-Derived Suppressor Cells to the Nonsteroidal Anti-Inflammatory Agent Indomethacin in Tumor-Associated and Tumor-Free Microenvironments 2015 ·The Journal of Immunology ·Ada G. Blidner, Mariana Salatino, Iván Mascanfroni, Miriam Diament, Elisa Bal de Kier Joffé, María A. Jasnis, (unknown), Gabriel A. Rabinovich	28
7	IL-21 induces IL-22 production in CD4+ T cells 2014 ·Nature Communications ·Ada Yeste, Iván Mascanfroni, Meghan Nadeau, Evan Burns, Ann-Marcia C. Tukpah, Andrezza Fernanda Santiago, Chuan Wu, Bonny Patel, Deepak Kumar, Francisco J. Quintana	131
8	Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors 2014 ·Cell ·Diego O. Croci, Juan P. Cerliani, Tomás Dalotto‐Moreno, Santiago P. Méndez‐Huergo, Iván Mascanfroni, Sebastián Dergan‐Dylon, Marta A. Toscano, Julio J. Caramelo, Juan J. García‐Vallejo, Jing Ouyang, Enrique A. Mesri, Melissa R. Junttila, Carlos Bais, Margaret A. Shipp, Mariana Salatino, Gabriel A. Rabinovich	414
9	Role and therapeutic value of dendritic cells in central nervous system autoimmunity 2014 ·Cell Death and Differentiation ·Francisco J. Quintana, Ada Yeste, Iván Mascanfroni	37
10	Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation 2014 ·Nature Medicine ·Lior Mayo, Sunia A. Trauger, Manon Blain, Meghan Nadeau, Bonny Patel, Jorge I. Alvarez, Iván Mascanfroni, Ada Yeste, Pia Kivisäkk, (unknown), Benjamin Ellezam, Rohit Bakshi, Alexandre Prat, Jack P. Antel, Howard L. Weiner, Francisco J. Quintana	367
11	Functional Toll-like receptor 4 expressed in lactotrophs mediates LPS-induced proliferation in experimental pituitary hyperplasia 2013 ·Experimental Cell Research ·(unknown), Liliana del Valle Sosa, (unknown), Jorge Humberto Mukdsi, Iván Mascanfroni, Claudia G. Pellizas, Silvina Gutiérrez, Alicia Inés Torres, Ana Lucía De Paul	12
12	IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 2013 ·Nature Immunology ·Iván Mascanfroni, Ada Yeste, Sílvio M. Vieira, Evan Burns, Bonny Patel, Ido Sloma, Yan Wu, Lior Mayo, Rotem Ben‐Hamo, Sol Efroni, Vijay K. Kuchroo, Simon C. Robson, Francisco J. Quintana	269
13	Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration 2012 ·Immunity ·Sarah C. Starossom, Iván Mascanfroni, Jaime Imitola, Li Cao, Khadir Raddassi, Sílvia Hernández, Ribal Bassil, Diego O. Croci, Juan P. Cerliani, Delphine Delacour, Yue Wang, Wassim Elyaman, Samia J. Khoury, Gabriel A. Rabinovich	285
14	Dexamethasone counteracts the immunostimulatory effects of triiodothyronine (T3) on dendritic cells 2011 ·Steroids ·(unknown), (unknown), Iván Mascanfroni, Sebastián Susperreguy, (unknown), Ana M. Masini‐Repiso, Gabriel A. Rabinovich, Claudia G. Pellizas	23
15	Expanding the Universe of Cytokines and Pattern Recognition Receptors: Galectins and Glycans in Innate Immunity 2010 ·Journal of Clinical Immunology ·Juan P. Cerliani, Sean R. Stowell, Iván Mascanfroni, Connie M. Arthur, Richard D. Cummings, Gabriel A. Rabinovich	89
16	NF-κB p65 Subunit Mediates Lipopolysaccharide-Induced Na⁺/I⁻Symporter Gene Expression by Involving Functional Interaction with the Paired Domain Transcription Factor Pax8 2010 ·Molecular Endocrinology ·Juan P. Nicola, (unknown), Iván Mascanfroni, Claudia G. Pellizas, Ana M. Masini‐Repiso	56
17	Growth hormone treatment in children with idiopathic short stature: correlation of growth response with peripheral thyroid hormone action 2010 ·Clinical Endocrinology ·Sebastián Susperreguy, (unknown), (unknown), Iván Mascanfroni, (unknown), (unknown), Ana M. Masini‐Repiso, Mirta Miras, Claudia G. Pellizas	4
18	Nuclear Factor (NF)-κB-dependent Thyroid Hormone Receptor β1 Expression Controls Dendritic Cell Function via Akt Signaling 2009 ·Journal of Biological Chemistry ·Iván Mascanfroni, María del Mar Montesinos, (unknown), Sebastián Susperreguy, Juan P. Nicola, Juan M. Ilarregui, Ana M. Masini‐Repiso, Gabriel A. Rabinovich, Claudia G. Pellizas	45
19	Growth hormone (GH) treatment reduces peripheral thyroid hormone action in girls with Turner syndrome 2007 ·Clinical Endocrinology ·Sebastián Susperreguy, Mirta Miras, (unknown), Iván Mascanfroni, (unknown), (unknown), (unknown), Ana M. Masini‐Repiso, Aldo H. Coleoni, Héctor M. Targovnik, Claudia G. Pellizas	10
20	Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells 2007 ·Journal of Endocrinology ·Laura Fozzatti, María Laura Vélez, (unknown), Juan P. Nicola, Iván Mascanfroni, Daniela R. Macció, Claudia G. Pellizas, German A. Roth, Ana M. Masini‐Repiso	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact